Ixico

1. 01 Oct 26
   IXICO present PD research at radiology conference

   IXICO to present advancements in neuroimaging for Parkinson’s disease at European radiology conference

   RNS 9800296 ↗
2. 27 Jul 26
   Share option award

   27 July 2026: IXICO plc (AIM: IXI), IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development and diagnostics in neurological disorders, today announced that the Company has issued...

   RNS 9689469 ↗
3. 15 Jul 26
   Director/PDMR Shareholding Director buys

   15 July 2026: IXICO plc (AIM: IXI), IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development and diagnostics in neurological disorders, announces that it has been notified that on...

   RNS 9670504 ↗
4. 13 Jul 26
   HD Industry Update

   13 July 2026: IXICO plc (AIM: IXI), IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development and diagnostics in neurological disorders, notes the continued evolution of the...

   RNS 9664195 ↗
5. 07 Jul 26
   Trading Update

   Revenue anticipated to be ahead of expectations for the year ending 30 September 2026

   RNS 9654825 ↗
6. 08 Jun 26
   Scientific advisors & partners update

   IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER'S AND PARKINSON'S DISEASE

   RNS 9605268 ↗
7. 22 May 26
   Company presentation at Mello 2026

   22 May 2026, IXICO plc (AIM: IXI) - London, UK.

   RNS 9581363 ↗
8. 21 May 26
   Contract win and contract extension

   Alzheimer's contract win and Phase 2 clinical trial contract extension with total value of £1.3 million

   RNS 9578728 ↗
9. 19 May 26
   Half-year Results

   Interim results for six months ending 31 March 2026

   RNS 9574199 ↗
10. 12 May 26
    IXICO Updates AI Neuroimaging Platform

    IXICO RELEASES LATEST VERSION OF AI-DRIVEN NEUROIMAGING TECHNOLOGY PLATFORM

    RNS 9562828 ↗
11. 21 Apr 26
    Trading Update

    Half-year Trading update and Notice of Interim Results

    RNS 9529275 ↗
12. 16 Apr 26
    Result of GM and Update on Issue of Equity

    Result of General Meeting and Update on Issue of Equity

    RNS 9524119 ↗
13. 07 Apr 26
    Result of Retail Offer

    IXICO is pleased to announce that the Retail Offer launched on 31 March 2026 has now closed, raising gross proceeds of £30,320.

    RNS 9508690 ↗
14. 31 Mar 26
    Retail Offer

    IXICO is pleased to announce a retail offer via the BookBuild Platform (the "Retail Offer") of up to 6,250,000 new ordinary shares ("Ordinary Shares") of £0.01 each in the capital of the Company (the "Retail Offer Shares") at an issue price of 8 pence per...

    RNS 9499392 ↗
15. 31 Mar 26
    Placings and Subscription

    THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY.

    RNS 9499214 ↗
16. 26 Mar 26
    Collaboration with Medidata

    IXICO and Medidata collaborate to create an advanced neuroimaging clinical trials platform

    RNS 9492601 ↗
17. 26 Feb 26
    Validation of Neuroimaging Technology Platform

    26 February 2026, IXICO plc (AIM: IXI) - London, UK.

    RNS 9447702 ↗
18. 12 Feb 26
    C.£1.5 million Contract Extension

    The following amendment has been made to the "c.£1.5 million Contract Extension" announcement released at 07:00 on 12 February 2026:

    RNS 9427870 ↗
19. 12 Feb 26
    C.£1.5 million Contract Extension

    c.£1.5 million contract extension on global Phase 2 clinical trial

    RNS 9427006 ↗
20. 05 Feb 26
    Appointment of Chief Commercial Officer

    IXICO appoints Chief Commercial Officer to accelerate business development activity and broaden US footprint

    RNS 9410111 ↗
21. 23 Jan 26
    Result of AGM

    IXICO plc (AIM: IXI), a global leader in neuroscience precision medicine and biomarker analytics, using its AI-driven platform to help advance drug development in neurological disorders, announces that all resolutions put forward to its Annual General...

    RNS 9381002 ↗
22. 09 Dec 25
    Share option award

    9 December 2025 IXICO plc (AIM: IXI) - London, UK.

    RNS 9284008 ↗
23. 09 Dec 25
    Financial Results for year ended 30 September 2025

    Financial Results for year ended 30 September 2025 and Notice of AGM

    RNS 9283736 ↗
24. 01 Dec 25
    Operational Update

    IXICO strengthens Scientific Advisory Board with two prominent global Alzheimer's Disease and vascular experts

    RNS 9265833 ↗
25. 27 Nov 25
    Notice of 2025 Full Year Results and IMC

    Notice of 2025 Full Year Results and Investor Presentation

    RNS 9260022 ↗
26. 17 Nov 25
    Clinical Trial Contract Win

    Global Phase 3 clinical trial contract win worth over £3.5 million

    RNS 9236517 ↗
27. 03 Nov 25
    Capital Markets Day Presentation and Video

    03 November 2025 IXICO plc (AIM: IXI) - London, UK.

    RNS 9209527 ↗
28. 16 Oct 25
    Trading Update

    Trading update for the year ended 30 September 2025

    RNS 9173985 ↗
29. 15 Oct 25
    New contract win and contract extension

    contract extension worth a total of £1.2 million.

    RNS 9171237 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.